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ARTICLE
T cell receptor β-chains display abnormal
shortening and repertoire sharing in type 1 diabetes
Iria Gomez-Tourino1,2,3, Yogesh Kamra1, Roman Baptista1,2, Anna Lorenc1 & Mark Peakman1,2
Defects in T cell receptor (TCR) repertoire are proposed to predispose to autoimmunity. Here
we show, by analyzing >2 × 108 TCRB sequences of circulating naive, central memory, reg-
ulatory and stem cell-like memory CD4+ T cell subsets from patients with type 1 diabetes and
healthy donors, that patients have shorter TCRB complementarity-determining region 3s
(CDR3), in all cell subsets, introduced by increased deletions/reduced insertions during VDJ
rearrangement. High frequency of short CDR3s is also observed in unproductive TCRB
sequences, which are not subjected to thymic culling, suggesting that the shorter CDR3s
arise independently of positive/negative selection. Moreover, TCRB CDR3 clonotypes
expressed by autoantigen-speciﬁc CD4+ T cells are shorter compared with anti-viral T cells,
and with those from healthy donors. Thus, early events in thymic T cell development and
repertoire generation are abnormal in type 1 diabetes, which suggest that short CDR3s
increase the potential for self-recognition, conferring heightened risk of autoimmune disease.
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Type 1 diabetes (T1D) results from immune-mediateddestruction of insulin-producing β-cells1. The vast major-ity of cases arise on a complex polygenic background,
characterized by major disease-predisposing genes in the HLA
region as well as much lower-risk allelic polymorphisms at >50
other immune gene loci (reviewed in ref. 2). As a consequence,
familial predisposition is a feature of T1D, especially when
affected family members share HLA haplotypes3, or are mono-
zygotic twins4,5. However, reported disease concordance in such
siblings and twins approximates only 50%4,5; thus beyond the
currently known genes, there is a considerable gap in our
understanding of what confers susceptibility to T1D. Whilst the
interaction of environment and genes is a potentially key modiﬁer
of risk5,6, there are as yet no concrete examples of this phe-
nomenon, and, therefore, alternative propositions to account for
missing heritability in T1D may be required.
One genetic element that cannot be revealed to be disease-
linked in genome studies, but could nonetheless have consider-
able bearing on T1D risk, is the gene loci encoding the antigen-
receptors borne by T and B lymphocytes. These receptors may
confer the property of autoantigen recognition, fundamental
bedrock of organ-speciﬁc autoimmune disease. For both cell
types, the antigen receptor is generated by random somatic
recombination of variable (V), diversity (D) and joining (J) genes,
selected from germline encoded gene families7. Further diversity
is engendered by variable degrees of nucleotide addition and
deletion at the recombination sites, and by TCRα and TCRβ
pairing7. As a result, highly diverse repertoires of antigen-
receptors are generated at the level of the individual8. It is a
guiding principle of autoimmune diseases such as T1D that
antigen-receptors with the capacity to recognize self-antigens
must be present within this repertoire in order for self-tolerance
to be breached and autoimmune disease to develop. This is
particularly true for the CD4+ T cell, which is viewed as the main
initiator and driver of autoimmunity in T1D9–11. According to
this model, CD4+ T cell recognition of β-cell autoantigens causes
an unregulated autoimmune response, inﬂammation and
destruction of islets of Langerhans, leading to clinical disease9–11.
An attractive hypothesis to account for missing heritability in
autoimmune disease is that risk is conferred by generation of an
autoreactive-prone TCR repertoire. It has been proposed that
TCR repertoires that are abnormally diverse (increases the
potential for self-reactive TCRs), abnormally shared amongst
individuals with disease (more likely that the repertoire contains
CD4+ T cell clones with self-reactive, pathogenic potential),
abnormally short (greater propensity to bind self HLA/
peptide12–17) or abnormally constituted (higher hydrophobicity
in the TCR-peptide-HLA interface seems to promote self-
reactivity in animal models18) represent dangerous features that
confer a risk of autoimmune disease that is additive to that
conferred in the germline by HLA and other regions.
High-throughput sequencing technology and multi-
dimensional ﬂuorescence-based sorting of highly pure T cell
subsets allow testing the hypothesis that features of the TCR
repertoire within cellular compartments confers risk of auto-
immune diseases. Here we present a large study of TCR repertoire
in autoimmunity (>200 million sequences and 18 million unique
clonotypes) performed on ex vivo sorted CD4+ T cell subsets.
Patients with T1D have abnormally high TCR repertoire relat-
edness, shortness and interfacial hydrophobicity. Moreover,
diversity, sharing and TCR clonotype length pre-thymic and post-
thymic selection are correlated, and TCRB rearrangement pat-
terns are aberrant in patients with T1D, suggesting a common
underlying pathway for autoimmunity. Our results also demon-
strate that TCRBs speciﬁc for autoantigens are shorter than their
anti-viral counterparts, providing a link between self-reactivity
and TCRB CDR3 length. These ﬁndings thus implicate abnormal
thymic recombination as a predisposing factor for T1D.
Results
TCRB sequences show greater diversity in T cells from T1D.
The T cell receptor beta chain (TCRB) repertoires of different
CD4+ T cell subsets (true naive, TN; central memory, CM; reg-
ulatory, Treg; and stem cell-like memory, Tscm) were examined
using next generation sequencing technology in 14 recently
diagnosed patients with type 1 diabetes (T1D) and 14 matched
healthy donors (HD) who did not differ in mean age, distribution
of gender, mean total cell number, cell subset yield or possession
of HLA-DRB1*0401 or *0301 haplotypes associated with T1D
(Supplementary Table 1; Supplementary Figs. 1a–e and 2a). The
ﬂow cytometric phenotype of sorted cell subsets was comparable
between patients and healthy donors (Supplementary Fig. 2b–e).
The number of cells per sorted subset correlated strongly with
RNA yield (Spearman's R= 0.75; p< 0.0001) and a total of
107,917,701 cells were examined, yielding >200 × 106 total and
>18 × 106 unique expressed TCRB sequences (productive unique
sequences). There were no differences in the number of unique
clonotypes obtained from patients and healthy donors for any of
the four cell subsets (Supplementary Fig. 2f). Thus, in these
experiments we sorted similar numbers of four major CD4+ T cell
subsets from matched patient and control cohorts; cells had
similar naive/memory ﬂow cytometric phenotypes and yielded
comparable numbers of unique clonotypes, allowing unbiased
comparison of their TCRB repertoires.
As expected, higher numbers of sorted cells yielded more
unique clonotypes (Fig. 1a). However, in the case of CM cells this
relationship is asymptotic, indicating that in this subset we are
close to sampling with sufﬁcient depth to assess total diversity. It
is also noteworthy that at equivalent numbers of sampled cells the
CM subset is less diverse than TN (i.e., has fewer unique
clonotypes), as might be predicted from the fact that CM cells
undergo antigen-driven selection from the TN pool. To examine
disease-related repertoire differences, normalized true diversity
index and Gini coefﬁcient (an index of clonality) were calculated
for each of the samples (Fig. 1b, c), showing a trend for TN and
CM cells from patients to be more diverse and less clonal, with
reduced clonality being observed in TN cells in patients. Both
diversity and clonality of Tregs are similar in the study groups,
contrary to reports of reduced diversity in this subset in the non-
obese diabetic mouse model19. Tscm cell diversity/clonality
was similar between the groups. Interestingly, individuals with
high diversity in the TN pool also have high diversity in the
CM and Tscm pools (Fig. 1d–f), consistent with CM and
Tscm propagating from TN. However, this does not apply to
Treg cells (Supplementary Fig. 3), for which none of the
diversity indices are correlated with those of corresponding
Tconv cells.
TCRB CDR3s are short and highly shared across T1D patients.
Abnormalities in diversity and clonality could result from
deviations in complementarity-determining region 3 (CDR3)
length and/or V and J gene usage (see below). Importantly, we
identiﬁed a moderate, statistically signiﬁcant reduction in TCRB
CDR3 sequence length in patients with T1D in all four cell
subsets (Fig. 2a–d. p< 0.0005 for TN and CM cells. p< 0.001 for
Treg and Tscm cells. One-sided bootstrap univariate
Kolmogorov–Smirnov test). To test whether these differences are
not an artifact of sub-sampling of cells and variable number of
reads among samples, we performed randomized sub-sampling
analysis and re-analyzed the TCRB CDR3 length distributions.
We ﬁnd that, even in the subsamples, T1D patients maintain a
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statistically signiﬁcant reduction in TCRB CDR3 length (Sup-
plementary Fig. 4. p< 0.05. Mann–Whitney U-test). We reasoned
that this biased TCRB CDR3 length could cause a higher degree
of sequence sharing, as with shorter sequences (and hence more
limited variability of sequence combinations), the likelihood of
two TCRB CDR3s being identical just by chance increases.
Indeed, it has been reported that highly shared TCR pools are
enriched in clonotypes bearing lower numbers of insertions20. To
examine this we calculated overlap indices for TCRB repertoires
of all cell subsets. As shown in Fig. 2e–i and Supplementary Figs 5
and 6, TN, CM and Treg cell subsets are more similar among
patients than amongst healthy donors. TN and CM cell reper-
toires are also more similar to each other in patients, consistent
with propagation of CM from TN cells, in line with the observed
correlation of the true diversity indices between these two cell
subsets (Fig. 1d). Interestingly, we ﬁnd a high degree of sharing of
TCRB nucleotide sequences between CM and Treg cells in both
healthy donors and T1D patients, supporting the concept that
Treg cells may also be peripherally derived21,22.
We next examined whether human leukocyte antigen (HLA)
haplotypes inﬂuence TCRB sequence overlap. Interestingly,
heterozygosity for the disease-predisposing haplotypes
DRB1*03/DRB1*0401/DQB1*02/DQB1*03 does not seem to result
in a more similar thymic TCRB repertoire, as the TN/TN overlap
indices are higher among patients with any other haplotype
(Supplementary Fig. 7). This is not the case, however, for overlap
among CM/CM, TN/CM and TN/Tscm cells (Supplementary
Figs 7 and 8), where values are higher for DRB1*03/DRB1*0401/
DQB1*02/DQB1*03 patients, pointing to these haplotypes having
greater inﬂuence over the shaping of the peripheral TCRB
repertoire.
The ﬁnding that diversity, sharing and length of the TCR
repertoire are abnormal in T1D led us to examine the relationship
between these metrics. Interestingly, we found that samples with
high TN sharing also show lower clonality indices (Supplemen-
tary Fig. 9a), and higher frequencies of shorter TCR clonotypes
(Supplementary Fig. 9b).
In summary, we ﬁnd that length of TCRB clonotypes, their
diversity and sharing are related, and each of these is abnormal in
T1D, suggesting a common altered underlying pathway.
Pre-selection T1D TCRB repertoires are also abnormal. T cells
with short TCRs could be a feature of the pre-selection TCR
rearrangement process; or could undergo preferential enrichment
during thymic negative and positive selection on self HLA; or a
combination of the two. To gain a better understanding of which
of these pathways is involved, we analyzed out-of-frame (OOF)
sequences of TN cells as a means of studying the pre-selection
TCR repertoire, as described elsewhere20,23,24. OOF sequences do
not translate into functional TCRB chains, and cannot, therefore,
directly inﬂuence TCR selection (Supplementary Fig. 10). Under
these circumstances, the frequencies of insertions, deletions and
VDJ gene usage can be examined without the confounding effects
of positive and negative selection. By further restricting this
analysis to TN cells, this approach has the additional advantage of
ensuring that the results are also not biased by antigen-speciﬁc
expansions.
Remarkably, and recapitulating our ﬁndings in productive
TCRBs in TN, CM, Treg and Tscm pools, pre-selection TCRB
CDR3s in patients with T1D are also shorter than those from
healthy donors (Fig. 3a) and display a greater degree of sequence
similarity (Fig. 3b–d). Interestingly, and as seen previously for
productive sequences (Supplementary Fig. 9), individuals with
higher percentages of short pre-selection clonotypes also show
high sharing indices (Fig. 3e) and lower clonality indices (Fig. 3f)
in the pre-selection repertoire.
Therefore, we examined whether the previously described
alterations in length, diversity and sharing in the TN post-
selection TCR repertoire in T1D patients are related to pre-
selection alterations. Indeed, we ﬁnd a strong positive correlation
between pre and post-selection TCRB CDR3 lengths (Fig. 4a),
with shorter TCRB CDR3s being enriched during thymic
selection (Fig. 4b), a ﬁnding consistent with previous
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reports12–17,25. It is important to note, however, that patients and
controls have similar degrees of enrichment of shorter clonotypes
(Fig. 4c). Therefore, the bias towards shorter TCRB CDR3s in
T1D patients must result from a higher input of shorter
clonotypes into thymic selection.
These data imply that abnormalities in the pre-selection
repertoire could underlie similar ﬁndings in the post-selection
repertoire. Indeed, this concept is borne out by a series of
additional observations: (i) samples with higher proportions of
shorter pre-selection TCRB CDR3s show higher sharing and
lower clonality in the post-selection repertoire (Fig. 4d, e); (ii) the
degree of pre-selection sharing positively correlates with the
amount of sharing and length distribution after selection (R=
0.70, p= 3.59 × 10−5; and R = 0.48, p= 0.009, respectively.
Pearson correlation); (iii) true diversity and Gini coefﬁcient
pre-selection indices strongly correlate with their corresponding
post-selection values (Fig. 4f, g); (iv) individuals with lower pre-
selection clonality indices also have higher TCR repertoire
sharing after selection (Fig. 4h).
In summary, we have shown that T1D patients present
alterations in the pre-selection TCRB repertoire, including an
increased frequency of shorter TCRB CDR3s, which undergo
enrichment during thymic selection. These pre-selection altera-
tions are perpetuated into the post-selection TN TCRB repertoire.
Pre-selection TCRB rearrangement events are abnormal in
T1D. Our data thus far show that TCRB CDR3 length abnorm-
alities are predominantly inﬂuenced by pre-selection events. Short
TCRB CDR3 lengths might arise from reduced insertions and/or
increased deletions during the TCRB rearrangement process (see
Supplementary Fig. 11). Therefore, to understand the molecular
basis for these features, we analyzed recombination events
(indels) in each of the 6 rearrangement positions (Vdels, Jdels,
D5dels, D3dels, n1ins and n2ins) (Fig. 5, and Supplementary
Fig. 12). The distributions of frequencies of indels in pre- versus
post-selection sequences indicate that TCRBs bearing excessively
long Vdels or long n1ins are culled (Fig. 5a, e; compare left and
right panels). In contrast, events in the D–J junction do not seem
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to substantially affect the chances of a TCRB passing through
thymic selection, since the distributions before and after selection
are quite similar (Fig. 5d, f; compare right and left panels).
We also found that pre-selection TCRBs in T1D patients
display medium and long Jdels, medium Vdels and long D5dels
and D3dels more frequently; this is associated with a lower
frequency of short deletions, especially for the Jdel site (Fig. 5d,
left panels). The insertion sites show the opposite patterns: higher
frequencies of medium n1ins and long n2ins (Fig. 5e, f, left
panels). Interestingly, for the post-selection TCRBs many of the
differences are maintained, suggesting that these alterations
survive through positive and negative selection (Fig. 5, right
panels, and Supplementary Fig. 12). These results are not biased
by HLA haplotypes, as T1D patients with the predisposing HLA
haplotype DRB1*03/DRB1*0401/DQB1*02/DQB1*03 are not out-
liers for any of the rearrangement events (Supplementary Fig. 12).
It has been shown in pre-selection repertoires that the deletion
proﬁles vary from gene to gene, and that these proﬁles are highly
conserved among healthy individuals24. This is suggestive of a
conserved sequence-dependent nuclease activity24. Therefore, we
next looked at VDJ gene usage in the pre- and post-selection
repertoires (Supplementary Figs. 13–15). However, only one V
gene (TRBV7-2) is under-represented in patients in the pre-
selection repertoire, and therefore VDJ usage is not likely to be
the factor explaining the altered indel patterns. In fact, alterations
in the deletion patterns in T1D patients (i.e., higher frequencies of
clonotypes bearing long deletions) are found for most V and J
genes, both for under-represented and equally used genes (Fig. 6).
This is suggestive of an increased gene-independent exonuclease
activity in patients during rearrangement.
In summary, we ﬁnd that patients with T1D make abnormally
fewer insertions and delete more nucleotides at VDJ recombina-
tion sites. These results imply that T1D is associated with major
thymic rearrangement abnormalities that severely impact upon
the characteristics of the peripheral repertoire.
T1D TCRB rearrangement impacts upon self-reactive poten-
tial. We next hypothesized that the abnormal thymic rearrange-
ment processes that we observe in T1D patients might manifest as
an extreme phenotype, namely the emergence of clonotypes that
are exclusive to the disease setting and which are short, with
abnormal indel patterns. We therefore deﬁned T1D-enriched
clonotypes (present in most patients and few healthy donors) and
HD-enriched clonotypes, with the opposite presence pattern. We
used cut-offs of presence in at least 7 out of 14 individuals
(≥50%) from one group and at most 2/14 (≤14%) in another
group, as this difference reaches p< 0.05 in Fisher’s Exact test.
This resulted in 2812 unique amino acid T1D-enriched sequences
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and 3695 HD-enriched unique amino acid sequences. These
clonotypes were found in TN cells (T1D-enriched: 60.31%. HD-
enriched: 61.13%), CM cells (T1D-enriched: 33.50%. HD-enri-
ched: 29.72%), Treg cells (T1D-enriched: 3.57%. HD-enriched:
4.45%) and Tscm cells (T1D-enriched: 2.65%. HD-enriched:
4.70%).
T1D-enriched clonotypes differed in several respects from their
control counterparts. First, they showed higher frequencies
(Fig. 7a), suggesting that they are more frequent in blood, and
may have undergone more rounds of expansion (in the case of
CM) or were common and seeded at higher frequency (in the case
of TN). Second, T1D-enriched clonotypes showed differential
usage of certain V families, V genes, and J genes (Fig. 7b–d).
Third, they present an extreme phenotype regarding TCRB CDR3
length; T1D-enriched clonotypes are much shorter than HD-
enriched (Fig. 7e), due to both a higher frequency of deletions and
lower frequency of insertions (Fig. 7f, g); these differences are
signiﬁcant for each of the 6 rearrangement positions (Supple-
mentary Fig. 16. Vdels: p< 1 × 10−14; Jdels: p< 1 × 10−73; D5dels:
p< 1 × 10−19; D3dels: p< 1 × 10−04; n1ins: p< 1 × 10−19; n2ins:
p< 1 × 10−08). These ﬁndings therefore recapitulate, to a more
extreme degree, the aberrations seen in T1D pre- and post-
selection TCR repertoires.
Finally, we compared amino acid usage in T1D-enriched versus
HD-enriched clonotypes. T1D-enriched clonotypes show prefer-
ential amino acid usage in the central CDR3B positions (P5–P11)
(Supplementary Fig. 17); interestingly, amino acids that are over-
represented in positions P6 and P7 include the hydrophobic
residues proline, alanine, valine, methionine, tryptophan, pheny-
lalanine and leucine. It has been reported that over-representation
of hydrophobic residues at positions P6 and P7 of the TCRB
CDR3 is a characteristic of self-reactivity18, although these
ﬁndings remain to be extended and their relevance clariﬁed.
Therefore, while the amino acid usage we observe in T1D-
enriched clonotypes suggests a self-reactive bias, additional
functional and structural analyses will be required.
In conclusion, we have shown that a disease-exclusive
component of the T1D TCR repertoire manifests an extreme
phenotype characterized by signiﬁcant shortening of the CDR3B
region (due to more deletions and fewer insertions), as well as
enhanced interfacial hydrophobicity.
Autoantigen-speciﬁc TCRB sequences are abnormally short. To
address the potential impact of short TCRB sequences on target
speciﬁcity we examined whether TCRB chains from autoreactive
T cells are shorter than virus-speciﬁc TCRs and fall within the
shorter region of CDR3B length distributions obtained by deep
sequencing (Fig. 2a–d).
For this analysis we used the same blood draw of 7/14 T1D
patients and 6/14 healthy donors to isolate CD4+ T cells speciﬁc
for the T1D autoantigen glutamic acid decarboxylase (GAD65)
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Fig. 4 Correlations between diversity, sharing and TCRB CDR3 length pre- and post- selection. a TCRB CDR3 length correlates between pre- and post-
selection repertoires. b Short TCRB CDR3s are enriched during thymic selection, both in type 1 diabetes patients (T1D) and healthy donors (HD) (paired
t-test. ***p< 0.001). c There are no differences in the degree of enrichment in short TCRB CDR3s in T1D patients versus HD (unpaired t-test. Lines
represent the mean± SD). d, e The percentage of pre-selection shorter clonotypes correlates positively with the post-selection sharing (d) and negatively
with the post-selection clonality (e). f, g Pre- and post-selection diversity indices correlate (f, true diversity; g, clonality). h Clonality of the pre-selection
repertoire correlates with post-selection sharing. a, d–h: Pearson's correlation
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and for cytomegalovirus (CMV) after stimulation in vitro26–28
and obtain TCRB sequences from single cells29. We identiﬁed 219
GAD65-speciﬁc TCRB sequences from 7 T1D patients, 155
GAD65-speciﬁc TCRB sequences from 6 healthy donors and 122
CMV-speciﬁc TCRB sequences from 1 control and 2 patients.
When all GAD65 clonotypes and all CMV clonotypes were
pooled and their lengths compared, we found that GAD65
CDR3B length distribution shows a higher frequency of short
clonotypes and a lower frequency of long ones compared with
CMV (Fig. 8a). To examine where these antigen-speciﬁc
clonotype lengths lie in relation to representative TCR repertoires,
their length distributions were compared with that of the global
TCR repertoire obtained from deep sequencing of healthy donors
(data from Fig. 2a–d). We found that, while CMV clonotypes
follow the same length distribution as the global TCRs (Fig. 8b),
GAD65 clonotypes are shorter (Fig. 8c).
We next aimed to validate these ﬁndings using autoreactive
TCR repertoires published in T1D studies. We found that
GAD65-speciﬁc clonotypes in T1D patients are shorter than in
non-diabetic autoantibody-positive patients30 (n= 479 and n=
7
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387, respectively; Fig. 8d, compare red and blue lines) and again,
these published T1D GAD65 clonotypes were shorter than the
healthy donors’ global TCR repertoire (Fig. 8d, compare red and
black lines). Interestingly, the CDR3B length distribution of
GAD65 clonotypes of non-diabetic autoantibody-positive
patients30 is not different to that of our healthy donor TCR
repertoires (Fig. 8d, compare blue and black lines). Note that the
CDR3B length distributions obtained from our own GAD65
single-cell data and GAD65 clonotypes from the literature30 are
almost identical (Fig. 8c, d, compare the shape of the red lines).
Finally, we also analyzed published TCR clonotypes from
autoreactive CD4+ T cells that have been identiﬁed by different
methods in the T1D setting31–38 (n= 39; Fig. 8e) as well as intra-
islet-proinsulin-speciﬁc CD4 T cell clonotypes39 (n= 8; Fig. 8f)
and compared these with the healthy donor TCR repertoire as
before. We found that the CDR3B length distribution for
proinsulin-speciﬁc39 and autoreactive clones31–38 shows a clear
trend to being shorter than expected (Fig. 8e, f).
Summarizing these comparisons, autoantigen-speciﬁc TCRB
clonotypes obtained after stimulation in vitro and from a variety
of published methods show reduced TCRB CDR3 length when
compared to both virus-speciﬁc clonotypes and a global TCRB
length distribution obtained from healthy donors. These ﬁndings
support the proposal that short TCR clonotypes present in
patients with the autoimmune disease T1D are associated with
autoreactivity.
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Fig. 6 Alterations in deletion patterns in patients are found in most V and J genes. Frequency of germline a, e, short b, f, medium c, g or long d, h deletions
for each of the V genes (a–d) and J genes (e–h) in type 1 diabetes (T1D) patients and healthy donors (HD). The gray shaded area represents V genes that
are differentially used in patients versus controls (Supplementary Fig. 14). The increased deletions pattern of T1D patients is seen both in under-
represented and equally used genes. The statistical test was performed for all genes or just for those equally used in T1D and healthy donors (i.e., without
those genes included in the shaded areas). Mixed effects two-way ANOVA with individual as random variable. Lines represent the mean± SD
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Discussion
There is a considerable gap in knowledge and understanding of
the factors beyond those encoded in the germline that predispose
to type 1 diabetes (T1D). Given the importance of autoreactive
CD4+ T cells in initiating and perpetuating β-cell autoimmunity,
we examined whether there are distinct, disease-associated fea-
tures of the T cell receptor (TCR) in this setting, which could
increase the risk of autoimmunity. We undertook a large exam-
ination of TCR repertoire characteristics in T1D to a degree not
achieved hitherto. Most striking are our observations that the
T1D TCR repertoire contains abnormally short β-chain CDR3
regions and that autoantigen-speciﬁc CD4+ T cells are enriched
for shortened TCRB CDR3 sequences. We also ﬁnd that TCR
repertoires in T1D are abnormal in the degree of their diversity,
publicity/sharing, and interfacial hydrophobicity. None of these
abnormalities has been described previously. These features are
not apparently human leukocyte antigen (HLA) or selection
determined; rather they precede, and are independent of thymic
selection events. Taken together these data suggest that early
events in thymic T cell development and repertoire generation are
abnormal, and have clear implications for a model of T1D risk
that results from a generalized, heightened degree of self-
recognition by T cells.
Our ﬁnding that pre- and post-selection TCRB repertoires are
enriched of TCRBs bearing shorter CDR3 loops, arises from a
combination of identifying more V/D/J deletions and fewer
insertions during TCRB rearrangement. A model can be proposed
to explain these ﬁndings (Fig. 9) in which random VDJ gene
rearrangement typically yields a pre-selection repertoire of TCRB
CDR3s across a range of lengths, but shorter lengths are favored
in T1D. Following rearrangement, TCRBs bearing short CDR3s
are enriched during positive selection12–17,25 and our own data
bear this out. As a consequence of these two biases operating in
series, the outcome of positive selection in T1D is a richer and
more diverse repertoire, and thus the pipeline into negative
selection is already abnormal. There is evidence from elsewhere
that negative selection events are dysregulated in T1D40,41,
causing failed deletion of autoreactive clonotypes. Thus, in our
proposed model, the overall outcome is a more diverse post-
selection repertoire, enriched in shorter clonotypes and highly
shared among patients: a series of features that is borne out
experimentally in the present study. Furthermore, our ﬁnding
that autoreactive TCRB CDR3s are shorter than anti-viral and
global, healthy donor repertoires suggests that diabetes-related
enrichment in short TCRs augments opportunities for auto-
reactivity. It is also notable that some of these ﬁndings have been
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reported in patients with Rasmussen’s encephalitis, an inﬂam-
matory disease of putative autoimmune origin42, suggesting that
these principles proposed by our model may be generalizable.
The mechanism through which more V/D/J deletions and
fewer insertions arise is not known. Selection of V, D and J genes
to be recombined is not stochastic; it depends upon recombina-
tion signal sequences43 and on the accessibility and epigenetic
modiﬁcations of the TCR loci44–46. Furthermore, there is evidence
that mutations in the recombination-activating genes 1 (RAG1)
and 2 (RAG2) generate TCR CDR3s with higher deletion rates,
apparently by recruiting the alternative instead of the classical
non-homologous end-joining pathway47–49. Hypomorphic poly-
morphisms in RAG are found in numerous immunodeﬁciency
syndromes associated with autoimmune manifestations50–52 and
it was proposed that this might give rise to diverse TCR reper-
toires that predispose to autoimmunity53. Alterations in the
insertion patterns can result from mutations in exon 9 of the
DNTT gene encoding the active site of the terminal deox-
ynucleotidyl transferase (TdT)54, although all T1D patients in the
present study had the wild-type exon 9 sequence The balance of
differentially spliced forms of TdT, which are known to differ in
N-nucleotide addition and exonuclease activities55, could also
impact upon insertion patterns. Individual variation in the efﬁ-
ciency of the N-nucleotide addition process has also been
described for B cell receptor (BCR) rearrangement56. Therefore, it
remains possible that one, or a combination of several factors
described previously, explain CDR3B length skewing. A sys-
tematic examination of the functional integrity of all of the
elements described, at all stages of T1D development, will prob-
ably be required to gain a better understanding of the underlying
mechanisms of abnormal TCRB chain generation.
Several other observations in our study are of interest and
could have bearing on the pathogenesis of T1D. True naive (TN)
cells exhibit greater sharing, which may reﬂect a widespread
impact of impaired TCR rearrangement and faulty negative
selection40,41. A propensity to greater sharing in the T1D TN cell
subset could be a consequence of the TCR rearrangement
alterations we describe. It has been suggested that TCRs with
fewer nucleotide insertions are more likely to be shared across
individuals23,57–60 and it is known that highly shared TCR pools
are enriched in clonotypes bearing lower numbers of insertions20.
HLA type did not appear to be a major confounder in our
study, as the highest T1D risk alleles did not associate with
excessive diversity, sharing or shortness, and our data point to
pre-selection rearrangement processes, which are HLA indepen-
dent, as being critical events. Nonetheless, numbers of individuals
are small in these sub-analyses and the possibility that HLA type
inﬂuences TCRB chain rearrangement will need to be clariﬁed. A
recent study has shown that usage of TCR Vα and Vβ genes is
associated with the HLA genotype61; however, this effect was
much stronger for Vα than Vβ genes, and Vβ genes whose per-
ipheral usage was affected by HLA genotype are not preferentially
enriched in our T1D cohort. In fact, the V gene usage is quite
similar among patients and healthy donors. The only alteration
found to be distinctive in T1D patients bearing DRB1*03/
DRB1*0401/DQB1*02/DQB1*03 is higher sequence sharing
cba
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versus cytomegalovirus (CMV)-speciﬁc (n= 122) TCRB clonotypes. b Cumulative plots of CMV-speciﬁc TCRB clonotypes versus healthy donor global TCR
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among central memory cells (CM) and between the TN and CM
compartments, which is consistent with a peripheral, rather than
central effect. To the extent that we could, other potential major
study confounders were addressed, such as age matching, since
ageing is related to thymic involution62 and decreased TCR
repertoire diversity63.
To gain a greater insight into disease-associated repertoire
effects, we deﬁned T1D-enriched and HD-enriched clonotypes.
T1D-enriched clonotypes have interesting properties, akin to an
extreme phenotype: they are present at higher frequencies, are
short, and bear marked interfacial hydrophobicity, a feature
associated with self-reactive mouse and human TCRB reper-
toires18 and which requires further examination in additional
settings.
High-throughput TCRB sequencing can be performed using
genomic DNA (gDNA) or cDNA synthesized from mRNA. We
elected to use cDNA in this study because we wished to focus on
expressed receptor transcripts, representing the circulating,
in vivo repertoire, and explore how these may deviate from
normal during an active autoimmune process. In our preliminary
studies (see Methods), TCRB repertoires showed a very high
degree of overlap when acquired from cDNA (rearranged and
expressed receptors) and gDNA (rearranged receptors, expression
not known), suggesting that the approaches may indeed provide
comparable results. The number of TCR templates available for
sequencing when using gDNA is lower than when using RNA,
giving the latter a broader repertoire coverage from a given
amount of starting template64. Future studies focused on direct
cDNA versus gDNA comparisons in large sample sets will be
required to establish the optimal approach for each different
study question.
Use of cDNA rather than gDNA is potentially susceptible to
the inﬂuence of TCR gene expression level per cell, and parti-
cularly to the potential bias caused by rare populations of highly
activated T cells, which may differ in the setting of an active
autoimmune disease. We saw no evidence that T1D patients and
healthy donors differed in activation levels or in CD3 expression,
even at the 99.9th percentile (see Methods). Although the pos-
sibility remains that a very small number of high TCR-expressing
cells inﬂuence some of our results, we observed a strong corre-
lation between number of cells analyzed and the number of
unique clonotypes sequenced, arguing against over-
representation of TCRs due to high RNA expression levels.
Furthermore, we avoided bias in calculating true diversity and
clonality indices by using normalization to cell number, sup-
ported by our observation that cell number and number of
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unique reads are highly correlated. In addition, most of our
analyses (including CDR3 length distribution, VDJ gene usage,
overlap calculation, indel analysis, correlations and T1D-enriched
versus HD-enriched analyses) were carried out on unique
sequences, avoiding biases due to differences in sequence fre-
quencies. A ﬁnal consideration in relation to technical biases that
could inﬂuence measurement of CDR3B length distributions is
that PCR might be more efﬁcient for shorter templates. However,
all PCR and sequencing reactions for HD and T1D patients were
conducted together and corrected simultaneously with the same
approach to avoid systematic error, so any potential for PCR
skewing toward the detection of shorter lengths would apply
equally to both T1D patient and healthy donor groups.
Future studies should also aim to examine the generalizability
of our ﬁndings (e.g., CD8+ T cell repertoire; other autoimmune
diseases; pre-T1D; rate of progression; age of T1D onset), as well
as gain a better understanding of the molecular mechanisms of
abnormal TCR rearrangement. In this respect, the outlier patient
with extreme insertion and Jdel patterns, although having an
unremarkable clinical history, warrants greater scrutiny of T cell
autoreactivity.
In summary, we show for the ﬁrst time extensive abnormalities
in TCRB rearrangement processes in an autoimmune disease
setting, ﬁndings consistent with the contention that
antigen–receptor repertoire should be included as a major con-
tributor to autoreactivity and thus disease risk.
Methods
Human subjects. 14 patients with new onset T1D and 14 healthy donors were
recruited into this study, which was approved by the South London Research Ethics
Committee 5, REC reference 08/H0805/14. All recruited patients and healthy
donors provided written informed consent. In the case of Treg and Tscm cells only
cells from 8 of the patients and 8 of the healthy donors were isolated. Patients and
healthy donors were typed for DRB1* and DQB1* alleles by the Tissue Typing
Service at Guy’s Hospital (London, UK).
Cell staining and sorting. An average of 116 mL of blood was obtained from a
single draw from volunteer into heparinised Vacuette tubes (Greiner Bio-one,
Gloucestershire UK). PBMCs were immediately isolated by density gradient cen-
trifugation using Lymphoprep (Axis-Shield PoC AS, Oslo, Norway), and a mean of
94 × 106 cells were directly stained with the following monoclonal antibodies
(indicated in brackets is clone name, catalog number and volume in μL used to
stain 35 × 106 PBMCs—for higher cell numbers volumes were increased accord-
ingly): anti-CD14 (HIB19, 561121, 5 μL), anti-CD19, (M5E2, 561391, 5 μL), anti-
CD3 (SK7, 641415, 62.5 μL), anti-CD4 (SK3, 345768, 25 μL), anti-CD8 (RPA-T8,
562311, 2.5 μL), anti-CD25 (M-A251, 555432, 200 μL), anti-CD45-RO (UCHL1,
337168, 20 μL), anti-CCR7 (150503, 562555, 62.5 μL), anti-CD95 (DX2, 561978,
25 μL) BD Biosciences; anti-CD127 (eBioRDR5, 45-1278-42, 50 μL) eBiosciences;
anti-CD27 (O323, 302830, 10 μL) Biolegend; and LIVE/DEAD Fixable Aqua Dead
Cell Stain (Thermoﬁsher). Flow cytometric sorting took place in a BD FACSAria II
ﬂow cytometer (Becton Dickinson, San Jose, CA, USA); the ﬂuids system was
ﬂushed before sorting with RNAse Zap (Thermoﬁsher). Events were gated as
shown in Supplementary Fig. 1, and TN, CM, Treg and Tscm cells sorted with a
ﬂow rate of 2000–5000 events/s into DNase/RNase-free Eppendorf tubes con-
taining 300 μL of RNase-free PBS, using a 70 μM nozzle. The cells were centrifuged
at 1500xg 10 min at room temperature, the supernatant discarded and the cell
pellet lysed with 350 μL of RLT buffer (QIAGEN). Lysates were stored at −80 °C
until further processing. All sorted populations were greater than 98% pure.
Samples were always stained and sorted in pairs (e.g., one healthy donor and one
T1D patient per experiment) to minimize batch effects.
RNA isolation and cDNA synthesis. RNA was isolated using the RNeasy Micro
kit (for samples with < 650,000 cells) or RNeasy Mini kit (for all other samples)
(QIAGEN. 74004 and 74106, respectively), following the manufacturer’s guidelines,
including treatment with DNase (RNase-Free DNase Set, QIAGEN, 79254) to
avoid contamination with genomic DNA. RNA was eluted twice with 14 μL (Micro
kit) or 30 μL (Mini kit) of RNase-free water, and quantiﬁed using a NanoDrop
1000 Spectrophotometer (Thermo Scientiﬁc). Isolated RNA was used on its entirety
for cDNA synthesis using the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, 4368814). Samples from healthy donors and T1D patients
were processed together to avoid batch effects, and each cell subset (TN, CM, Treg,
and Tscm) processed separately to impede cross-contamination.
Sequencing of TCRB repertoires. cDNA was sent to Adaptive Biotechnologies,
Corp., (Seattle, USA) for deep (TN, CM, and Treg cells) or survey (Tscm)
sequencing of TCRB sequences using the ImmunoSEQ assay23,65,66: a multiplex
PCR system is used to amplify TCRB sequences from the whole cDNA sample; this
approach generates 87-base-pair fragments capable of identifying the VDJ region
spanning each unique CDR3B. Amplicons are then sequenced using the Illumina
HiSeq platform. Using a baseline developed from a suite of synthetic templates,
computational corrections were used to correct for potential PCR bias65. Low
frequency reads were binned and both PCR and sequencing errors were removed as
described23,65,66. Brieﬂy, a nearest-neighbor algorithm based on Hamming distance
was used to collapse the data into unique sequences by merging closely related
sequences (Hamming distance ≤ 2). Singletons that do not have a consensus
sequence that they can merge into were considered sequencing errors and dis-
carded. Reads were compared against the IMGT database (www.imgt.org), yielding
for each TCRB read V, D, and J gene usage, CDR3B length (i.e., number of
nucleotides from the codon coding for the second conserved Cys in the V gene to
the codon coding for the conserved phenylalanine in the J gene), and number of
nucleotides deleted/inserted in each of the 6 rearrangement sites (Vdel, D5del,
D3del, Jdel, n1ins and n2ins). A mean of 3,568,713 (range 1,006,045–12,954,066)
and 1,008,767 (range 254,789–3,580,864) total reads were obtained for deep and
survey sequenced samples, respectively.
Bioinformatic analyses. Analyses shown in this study were performed using
Adaptive Biotechnology’s ImmunoSEQ online tool, the R package tcR67, KNIME,
GraphPad Prism, IBM SPSS Statistics 22, and in-house R scripts.
Comparison of cDNA and gDNA as nucleic acid source. To investigate the
appropriateness of RNA (and hence cDNA) for studying the TCRB repertoires
shown in this paper, we sorted TN and CM cells from 3 healthy donors (HD#15,
HD#16 and HD#17), to compare TCRB repertoires obtained from cDNA and
genomic DNA (gDNA) from the same sorted samples.
A mean of 3,232,311 TN cells (range 3,137,083–3,409,198) and 1,478,741 CM
cells (range 698,153–2,138,070) were sorted as described in Material and Methods
section. RNA and gDNA were isolated simultaneously from each of the samples
using the AllPrep DNA/RNA/Protein Mini Kit (QIAGEN, 80004). cDNA synthesis
and TCRB sequencing of both cDNA and gDNA material for each sample were
carried out as described in the Material and Methods section. Repertoire overlap
between cDNA and gDNA is very high (Supplementary Fig. 18).
Since the use of cDNA has the potential to over-represent rare populations of
highly activated T cells we examined our samples for evidence of differences in
activation levels between patients and controls. There was no difference in average
activation level of CM and TN cells (as measured by surface CD25 expression;
Supplementary Fig. 19a, b), or in the frequency of CD25+ cells (CM cells: HD,
40.08% ± 10.08%; T1D, 41.02% ± 6.37%. TN cells: HD, 4.84%± 2.80%; T1D,
6.33% ± 2.52%. p=NS. Student's t-test). A more focused analysis of the top 2% of
highly activated cells (CD25high) also demonstrated no difference in activation
levels (Supplementary Fig. 19c, d), including at the 99.9th centile. The top 2% and
99.9th centile of highly activated cells also did not differ for CD3 expression (as a
surrogate for TCR expression. Supplementary Fig. 19e, f). Thus in this sample set,
with this approach, we did not ﬁnd evidence of a difference in highly activated
populations in the circulation in patients compared with healthy donors. As a
result of these preliminary studies, we elected to use cDNA for sequencing in order
to assess the repertoire of expressed (and not only rearranged) receptors.
Calculation of diversity indices. Diversity indices are highly inﬂuenced by dif-
ferences in sample size. To control for differences in sample size and depth of
sequencing the count of each clonotype was normalized to the cell number as
follows:
Normalized counti;y ¼ CountiCell numbery ´ cell number of sample with lowest cell number
ð1Þ
where i is a particular clonotype appearing in sample y. This normalization of
counts took place separately for each of the four cell subsets; therefore, the nor-
malization factor cell number of sample with lowest cell number was 1 × 106 for
TN, 363,555 for CM, 210,070 for Treg and 52,626 for Tscm samples. A detection
limit for rare clonotypes was deﬁned as the normalized count of the rarest clo-
notype in the sample with the lowest cell number among all samples of the given
cell type; all clonotypes with normalized counts lower than the detection limit were
excluded from calculations of diversity measures. True diversity and Gini coefﬁ-
cient (a measure of clonality) were calculated using the tcR package67. Both
parameters were calculated as they provide complementary information about the
overall diversity of one given sample.
Calculation of overlap indices. Sharing among TCR repertoires was quantiﬁed by
calculating the overlap coefﬁcient (overlap (X, Y)= |X and Y|/min (|X|, |Y|) for
nucleotide sequences (species= nucleotide sequence).
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Correlations analyses. Correlations were calculated using Pearson correlation (for
parametric variables) or Spearman (for non-parametric variables). Some new
variables were created to be able to calculate meaningful correlations within and
among pre- and post-selection repertoires. Sharing cell type 1/cell type 2 refers to
the mean cell type 1 to cell type 2 overlap coefﬁcients of a given individual with all
other individuals. To be able to correlate frequency of appearance of short TCRB
CDR3s with other variables we calculated the cumulative frequency of post-
selection TCRB CDR3s of 27–42 nucleotides long (percentage of shorter post-
selection clonotypes), and the cumulative frequency of pre-selection TCRB CDR3s
of 14−41 nucleotides long (percentage of shorter pre-selection clonotypes).
Analysis of insertion and deletion patterns. For each of the 6 rearrangement
sites (Vdel, D5del, D3del, Jdel, n1ins, and n2ins) the frequency of clonotypes
bearing a particular number of indels was calculated for TN cells of each of the 28
individuals (the example below relates to post-selection Vdels; the same approach
was followed for all 6 rearrangement sites and for pre- and post-selection reper-
toires):
Frequency of post selection iVdels ¼ n of productive unique clonotypes with iVdels
total number of productive unique clonotypes
´ 100
ð2Þ
where i refers to a particular number of Vdels. In the case of pre-selection analyses
the same formula was employed, using OOF sequences instead of productive
sequences.
In some cases the indel patterns are shown classiﬁed into germline, short,
medium and long. Indels were classiﬁed as follows (the numbers refer to the length
in nucleotides of the relevant rearrangement event): germline (no deletions/
insertions); short: 1–11 (Vdel, Jdel), 1–5 (D5del, D3del), 1–12 (n1ins), 1–13
(n2ins); medium: 12–21 (Vdel), 6–9 (D5del), 6–8 (D3del), 12–18 (Jdel), 13–20
(n1ins), 14–19 (n2ins); long: 22–65 (Vdel), 10–11 (D5del), 9–10 (D3del), 19–25
(Jdel), 21–32 (n1ins), 20–37 (n2ins). A cumulative frequency was then calculated
for each of the 4 classes and the 6 rearrangement sites, both for pre- and post-
selection repertoires. Which lengths to include in each class (for each of the 6
rearrangement sites) was decided by examining the frequency distribution of all
possible lengths in Fig. 5. In the case of n1ins the outlier highlighted in green in
Supplementary Fig. 12 was removed for statistical analyses (see comments in
Discussion). In the case of Jdel the class 17 nucleotides was not included in the
calculation described above for Medium Jdels as this class behaves as an outlier
when compared to the other Jdel classes (Fig. 5d), and would bias the interpretation
of the statistical analyses.
To analyze which variables affect the frequency of Vdels we performed, for the
pre-selection repertoire (i.e., TN out of frame sequences), a mixed effects two-way
analysis of variance for the frequency of Vdel, with type of individual (T1D patient
or healthy donor) and V gene as ﬁxed factors and individual as random variable
(full factorial model). The frequencies of Vdels were calculated for each of the 28
individuals and each of the 53 V genes as follows:
Frequency of iVdels for TCRBVX ¼ Log10
n of TCRBVXunique clonotypes with iVdels
total number of unique clonotypes
 
´ 100þ 1
 
ð3Þ
where i refers to a particular number of Vdels (range 0–65), and TCRBVX refers to
one of the 53 V genes included in the analysis. The analysis was carried out for all V
genes or just for the V genes equally used between T1D patients and healthy
donors, to account for potential interference of differentially used V genes in the
model (gray shaded areas in Fig. 6a). The same approach was used to investigate
which variables affect the frequency of Jdels.
Amino acid usage in T1D- and HD-enriched clonotypes. Analysis of amino acid
usage in T1D-enriched versus HD-enriched clonotypes was performed using Ice-
Logo68. IceLogo builds on probability theory to visualize signiﬁcant conserved
sequence patterns in multiple peptide sequence alignments against background
(reference) sequence sets that can be tailored to the system studied and protocol
used. T1D-enriched clonotypes were compared against HD-enriched clonotypes
(negative reference set) for each of the more frequent TCRB CDR3 lengths (12–15
amino acids long). All settings were left as default, and fold change was chosen as
the scoring system. The IceLogo plots show those amino acids whose usage is
signiﬁcantly different (i.e., p< 0.05) between T1D-enriched and HD-enriched
clonotypes.
Isolation of antigen-speciﬁc CD4 T cells and single-cell PCR. We isolated
antigen-speciﬁc CD4+ T cells using an assay previously developed by Roederer and
colleagues26,27 and adapted by us for this purpose28. Brieﬂy, from the same blood
draw of 7 of the described 14 T1D patients and 6 of the described 14 healthy
donors, fresh PBMCs (2 × 107 per antigen condition) were incubated at 106 cells/
mL in 48-well plates (37 °C, 5% CO2, 1 mL/well) in RPMI 1640 with Glutamax
supplemented with penicillin/streptomycin, Amphotericin B (Fisher Scientiﬁc,
15140 and 15290) and 10% human AB serum (Sigma, H4522) containing 2 μg/mL
of anti-CD40 monoclonal antibody (Biolegend, clone G28.5, 303611) and 10 μg/mL
of either GAD65 protein (Dyamid Diagnostics, 10-65702-15-01), CMV grade 2
antigen (containing antigens from all parts of the virus cycle of replication,
Microbix Biosystems Inc, EL-01-02). As a positive control 2 × 106 PBMCs were
incubated as above with 10 μg/mL of the polyclonal stimulus Staphylococcal
enterotoxin B (SEB, Sigma-Aldrich, S4881). The negative control consisted on 2 ×
106 PBMCs incubated as above with no additional stimulus. Non-adherent cells
were harvested after 18 h, washed, and stained with the following ﬂuorochrome-
conjugated monoclonal antibodies (indicated in brackets is clone name, catalog
number and volume in μL used to stain 2 × 106 PBMCs—for higher cell numbers
volumes were increased accordingly): anti-CD14 (TuK4, MHCD1428, 2 μL), anti-
CD19 (SJ25-C1, MHCD1928, 2 μL) (Invitrogen); anti-CD3 (SK7, 641415, 2 μL),
anti-CD154 (TRAP1, 555700, 2.5 μL), anti-CD69 (FN50, 555530, 2.5 μL) (all from
BD Biosciences); anti-CD4 (SK3, 46-0047-42, 3 μL. eBiosciences); and LIVE/DEAD
Fixable ViVid Dead Cell Stain (Molecular Probes, L34955).
Flow cytometric sorting took place in a BD FACSAria II ﬂow cytometer (Becton
Dickinson, San Jose CA, USA) with FACSDiva software version 7.0. The ﬂuids
system was ﬂushed before sorting with RNAse Zap (Thermoﬁsher, AM9780). FSC
and SSC doublets were excluded, and live CD3 + lymphocytes were deﬁned as
CD19− CD14− CD3+ ViViD−. Live CD3+ lymphocytes were further gated by FSC/
SSC, and CD4+ cells gated. Antigen-speciﬁc CD4+ T cells were further deﬁned as
CD154+ CD69+26–28, and sorted with a ﬂow rate of 2000–5000 events/s into 96-
well PCR plates (Thermoﬁsher) containing 5 µL of RNAse/DNase-free PBS, using a
70 μM nozzle. Plates were snap frozen in dry ice and stored at −80 °C until
processing.
Single-cell PCR was performed as described previously29. Brieﬂy, cDNA was
synthesized directly from single cells using 10 μL of qScript cDNA Supermix
(Quanta Biosciences, 95048-025). A ﬁrst round of PCR was done on total cDNA
using TATAA GrandMaster Mix (TATAA Biocenter, TA05-50) in the presence of
a mix of forward tagged variable region primers covering all Vβ genes and a reverse
constant TCRB region primer (Supplementary Table 2) with the following
conditions: 1 cycle of 95C 8′; 20 cycles of 95 °C 45″, 49C 1′ (with an increase of 0.3
°C per cycle), 72C 1′30″; 1 cycle of 72C 7′. A seminested second round PCR was
performed on 3 μL of the ﬁrst round product, using the tag primer (HTSP oligo)
and a nested constant region primer (Supplementary Table 2), with Takara ExTaq
DNA polymerase (Takara BIO INC, RR001A), with the following conditions:1
cycle of 94C 1′; 40 cycles of 56C 40″, 72C 30″; 1 cycle of 72C 6′. Each single-cell
PCR product was Sanger sequenced using the HTSP oligo, and the sequencing
results referenced to the IMGT database69, to obtain V, D, and J gene usage,
CDR3B length, and number of nucleotides deleted/inserted in each of the 6
rearrangement sites (Vdel, D5del, D3del, Jdel, n1ins, and n2ins).
Statistical analysis. For comparisons of two groups, paired or unpaired two-tailed
t-student t-test (for normally distributed variables) or Mann–Whitney U-test (for
other variables) were used. When pertinent, Benjamini-Hochberg multiple com-
parisons correction (false discovery rate—FDR—of 0.05) was applied. Pearson’s χ2-
t-test or Fisher’s exact test were used for comparing groups in analysis involving
qualitative variables. One-sided bootstrap version of univariate
Kolmogorov–Smirnov test was used for variable distribution comparisons. Unless
otherwise stated, bars represent means and error bars standard deviations. In box-
and-whisker plots, the box extends from the 25th to 75th percentiles, line repre-
sents the median and whiskers the minimum and maximum values.
Subsampling method. To test whether observed differences (such as those in
TCRB CDR3 length) are not an artifact of sub-sampling of TN cells and variable
number of reads among samples, we performed binomial sampling of the number
of sequences in the least abundant sample for each sample, for TN cells. This was
repeated 500 times and TCRB CDR3 length distributions were computed for each
replication. Frequencies of occurrence of each length were compared between T1D
patients and healthy donors with Mann–Whitney U-test.
Data availability. All sequencing data have been deposited and made public in the
Open Science Framework database (DOI 10.17605/OSF.IO/YDGTV)70: http://osf.
io/ydgtv/. All other data are available from the authors upon reasonable requests.
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